Looking for answers to urgent questions about the research impact of COVID-19?

Return to Coronavirus Guidance Main Page

Advarra stands together with the research community during the COVID-19 crisis. We offer free resources to address the impact of COVID-19 on ongoing clinical trials and prioritize reviews of new COVID-19 studies.

Advarra has compiled the following list of external regulatory guidance documents and other resources to help sponsors, sites, and IRBs remain compliant during this challenging time. This summary is updated as new information becomes available. If you want to receive alerts when we update this page, sign up here for email notifications.

Topics

IRB Guidances and Other Resources Revised

Return to top

US:

Canada:

Estonia:

Europe:

Italy:

Spain:

UK:

Return to top

Ready for Solutions That Are Altogether Better?